Haloperidol Prophylaxis in Older Emergency Department Patients (HARPOON)
This study has been completed.
VU University Medical Center
Information provided by (Responsible Party):
Prabath W.B. Nanayakkara, VU University Medical Center
First received: December 22, 2011
Last updated: November 25, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||October 2015|
|Primary Completion Date:||April 2015 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Schrijver EJ, de Vries OJ, Verburg A, de Graaf K, Bet PM, van de Ven PM, Kamper AM, Diepeveen SH, Anten S, Siegel A, Kuipéri E, Lagaay AM, van Marum RJ, van Strien AM, Boelaarts L, Pons D, Kramer MH, Nanayakkara PW. Efficacy and safety of haloperidol prophylaxis for delirium prevention in older medical and surgical at-risk patients acutely admitted to hospital through the emergency department: study protocol of a multicenter, randomised, double-blind, placebo-controlled clinical trial. BMC Geriatr. 2014 Aug 28;14:96. doi: 10.1186/1471-2318-14-96.